Concentrations of vascular endothelial growth factor in the sera of gastric cancer patients

Oncology Reports

Volumn 5, Issue 6, 1998, Pages 1419-1424

  Kitamura, Masatsugu ^a   Toi, Masakazu ^a   Arai, Kuniyoshi ^a   Iwasaki, Yoshiaki ^a   Suzuki, Hideo ^b   Matsuo, Katsuhiko ^b  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^b Base Technology Center   (Japan)

Author keywords

Vascular endothelial growth factor, gastric cancer

Indexed keywords

VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; BLOOD LEVEL; CANCER GROWTH; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CONTROLLED STUDY; CORRELATION FUNCTION; ENDOCRINE FUNCTION; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; STOMACH CANCER;

EID: 0031695228     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.6.1419     Document Type: Article

References (39)

1. Folkman J: What is the evidence that tumors are angiogensesis dependent? J Natl Cancer Inst 82: 4-6, 1990.
2. Liotta LA, Steeg PS and Stetler-Stevenson WG: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327-336, 1991.
3. Weidner N, Sample JP, Welch WR and Folkman J: Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 324: 1-8, 1991.
4. Moscatelli D and Rifkin B: Membrane and matrix localization of proteases: a common theme in tumor cell invasion and angiogenesis. Biochim Biophys Acta 948: 67-85, 1988.
5. Goldfarb M: The fibroblast growth factor family. Cell Growth Differ 1: 439-445, 1990.
6. Tisher E, Gospodarowicz D, Mitchell R, Suva M, Shilling J, Lau K, Crisp T, Fiddes JC and Abraham JA: Vascular endothelial growth factor: a new member of the platelet-derived growth factor gene family. Biochem Biophys Res Commun 165: 1198-1206, 1989.
7. Schrieber AB, Winkler ME and Derynck R: Transforming growth factor-α: a more potent angiogenic mediator than epidermal growth factor. Science 232: 1250-1253, 1986.
8. Ishikawa F, Miyazono K, Hellman U, Drexler H, Werustedt C, Hagiwara K, Usuki K, Takaku F, Risau W and Heldin CH: Identification of angiogenic activity and the cloning and expression of platelet derived endothelial cell growth factor. Nature 338: 557-562, 1989.
9. Bussolino F, di Renzo MF, Ziehe M, Bocchietto E, Olivero M, Naldini L, Gaudino G, Tamagnoue L, Coffer A and Comoglio PM; Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 119: 629-641.1992.
10. Kim KJ, Li B, Winer J, Armanini M, Gillet N, Phillips HS and Ferrara N: Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 362: 841-844, 1993.
11. Kondo S, Asano M and Suzuki H: Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth. and its inhibition by the antibody. Biochem Biophys Res Commun 194: 1234-1241, 1993.
12. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS and Dvorak HF: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219: 983-985, 1993.
13. Ferrara N and Henzel WJ: Pituitary follicular cells secrete a novel heparin-bmding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161: 851-858, 1989.
14. Leung DW, Cachianes G, Kuang W, Goeddel DV and Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309, 1989.
15. Keck PJ, Hause SD, Krivi G, Sanzo K, Warren T, Reder J and Cormolly DT: Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246: 1309-1312, 1989.
16. Houch KA, Ferrara N, Winer H, Cachianes G, Li B and Leung DW: The vascular endothelial growth factor family. Identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 5: 1806-1814, 1991.
17. Toi M, Hoshina S, Takayanagi T and Tominaga T: Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn J Cancer Res 85: 1045-1049, 1994.
18. Plate KH, Breire G, Weich HA and Risau W: Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature 359: 845-848, 1992.
19. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Senger DR and Dvorak HF: Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinoma of gastrointestinal tract. Cancer Res 53: 4727-4735, 1993.
20. Brown SF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Dvorak HF and Senger DR: Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinoma. Am J Pathol 143: 1255-1262, 1993.
21. Olson TA, Mohanraj D, Carson LF and Ramakrishnan S: Vascular permeability factor gene expression in normal and neoplastic human ovaries. Cancer Res 54: 276-280, 1994.
22. Zhang HT, Craft P, Scott P, Ziech M, Weich HA, Harris AL and Bicknell R: Expression of vascular endothelial growth factor in MCF-7 cells enhances tumor growth and vascular density. J Natl Cancer Inst 87: 213-219, 1995.
23. Japanese Research Society for Gastric Cancer: The general rules for the gastric cancer study. Kanehara Print Co., 12, 1993.
24. Holmgren L, O'Reilly MS and Folkman J: Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1: 149-153, 1995.
25. O'Relly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses' M, Lane WS, Cao Y, Sage EH and Folkman J: Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by Lewis lung carcinoma. Cell 79: 315-328, 1994.
26. Yeo K-T, Wang HH, Nagy JA, Sioussat TM, Ledbetter SR, Hoogewerf AJ, Zhou Y, Masse EM, Senger DR, Dvorak HF and Yeo T-K: Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions. Cancer Res 53: 2912-2918, 1993.
27. Kondo S, Asano M, Matsuo K, Ohmon I and Suzuki H: Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients. Biochim Biophys Acta 1221: 251-214, 1994.
28. Hanatani M, Tanaka Y, Kondo S, Ohmori I and Suzuki H: Sensitive chemiluminescence enzyme immunoassay for vascular endothelial growth factor/vascular permeability factor in human serum. Biosci Biotechnol Biochem 59: 1958-1959, 1995.
29. Ferrara N, Houch KA, Jakeman LB, Winer J and Leung DW: The vascular endothelial growth factor family of polypeptides. J Cell Biochem 47: 211-218, 1991.
30. Friedlander M, Brooks PC, Shaffer RW, Kincaid CM, Varner JA and Cheresh DA: Definition of two angiogenic pathways by distinct α integrines. Science 270: 1500-1502, 1995.
31. Yamamoto Y, Toi M, Kondo S, Matsumoto T, Suzuki H, Kitamura M, Turuta K, Tanuguchi T, Okamoto A, Mori T, Yoshida M, Ikeda T and Tominaga T: Cocentration of vascular endothelial growth factor in the sera of cancer patients. Clin Cancer Res 2: 821-826, 1996.
32. Henk Verheul MW, Hoekman K, Luykx-de Bakker S, Cornelis Eekman A, Claudia Folman C, Henk Broxterman J and Herbert Pinedo M: Platelet: transporter of vascular endothelial growth factor. Clin Cancer Res 3: 2187-2190, 1997.
33. Kurobe M, Kato A, Takei Y and Hayashi K: Fluorometric enzyme immunoassay of basic fibroblast growth factor with monoclonal antibodies. Clin Chem 38: 2121-2123, 1992.
34. Ii M, Yoshida H, Aramaki Y, Masuya H, Hada T, Terada T, Hatanaka M and Ichimori Y: Improved enzyme immunoassay for human basic fibroblast growth factor using a new enhanced chemiluminescence system. Biochem Biophys Res Commun 193: 540-545, 1993.
35. Takei Y, Kurobe M, Uchida A and Hayashi K: Serum concentrations of basic fibroblast growth factor in breast cancer. Clin Chem 40: 1980-1981, 1994.
36. Nguyen M, Watanabe H, Hudson AE, Richie JP, Hayes DF and Folkman J: Elevated levels of an angiogenic peptide, basic fibroblast growth factoide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst 86: 356-361, 1994.
37. Taniguchi T, Kitamura M, Arai K, Iwasaka M, Arai K, Iwasaki Y, Yamamoto Y, Igari A and Toi M: Increase in the circulating level of hepatocyte growth factor in gastric cancer patients. Br J Cancer 75: 673-677, 1997.
38. Taniguchi T, Toi M, Inada K, Imazawa T, Yamamoto Y and Tominaga T: Serum concentrations of hepatocyte growth factor in breast cancer patients. Clin Cancer Res 1: 1031-1034, 1995.
39. Gasparini G and Harris AL: Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognosis tool. J Clin Oncol 13: 765-782, 1995.